Here's How Much You Would Have Made Owning Regeneron Pharmaceuticals Stock In The Last 15 Years

Why is Procter & Gamble cutting 7,000 jobs? How will Trump's trade bill impact Wall Street? What caused Tesla's recent stock decline? Why did the ECB cut interest rates again? How are US-China trade talks affecting markets? What effects do Trump’s tariffs have on US imports? Why is Circle's IPO drawing investor attention?

Here's How Much You Would Have Made Owning Regeneron Pharmaceuticals Stock In The Last 15 Years

benzinga.com/insights/news/25/06/45760873/heres-how-much-you-would-have-made-owning-regeneron-pharmaceuticals-stock-in-the-last-15-years

Regeneron Pharmaceuticals (NASDAQ:REGN) has outperformed the market over the past 15 years by 9.69% on an annualized basis producing an average annual return of 21.89%. Currently, Regeneron Pharmaceuticals has a market capitalization of $52.77 billion.
Buying $100 In REGN: If ...
Full…

This story appeared on benzinga.com, 2025-06-03 21:45:15.